Methamphetamine induces hepatotoxicity via inhibiting cell division, arresting cell cycle and activating apoptosis:...

Area of Science:

• Hepatology
• Toxicology
• Molecular Biology

Background:

• Methamphetamine (METH) is known to cause acute hepatic injury.
• The precise mechanisms underlying METH-induced liver damage remain unclear.
• Understanding these mechanisms is crucial for developing potential therapeutic interventions.

Purpose of the Study:

• To elucidate the molecular mechanisms of METH-induced hepatotoxicity.
• To investigate the roles of cell cycle regulation and apoptosis in METH-induced liver injury.
• To identify key genes and pathways involved in METH-induced liver damage.

Main Methods:

• Rats were administered METH (15 mg/kg B.W.) via intraperitoneal injection for 8 days.
• Serum levels of liver enzymes and ammonia were measured.
• Liver tissues were analyzed using microarray, RT-qPCR, and Western blotting.
• Brl-3A cells were treated with METH to assess cytotoxicity and cell cycle effects.

Main Results:

• METH administration significantly elevated serum alanine transaminase, aspartate transaminase, and ammonia levels, indicating liver injury.
• Microarray analysis revealed differential expression of 332 genes, with significant down-regulation of cell cycle genes.
• METH treatment induced cell cycle arrest and apoptosis, evidenced by the overexpression of Cidea, cleaved caspase 3, and PARP 1.
• METH exposure caused cytotoxic responses and cell cycle arrest in Brl-3A cells.

Conclusions:

• Methamphetamine induces hepatotoxicity through the induction of cell cycle arrest.
• Activation of apoptosis plays a significant role in METH-induced liver damage.
• This study provides insights into the molecular pathways of METH-induced liver injury.